Term ends Jun 11, 2035 · High confidence
20-year base term ends Jun 11, 2035
Held by Mayne Pharma LLC
Filed Jun 11, 2015 as application 14/737,360 · Granted Oct 31, 2017
Base term, 20 years from filing
Today
2015
2035
Clock starts
Jun 11, 2015
Jun 11, 2015
Term ends
Jun 11, 2035
Jun 11, 2035
Granted
Oct 31, 2017
Oct 31, 2017
base term
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 11, 2015, when this application, 14/737,360, was filed | Jun 11, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 11, 2035 | High confidence |
This family
| US 9,801,857 | this patent Jun 2035 | Jun 2035 |
| US 9,974,773 | In force Jun 2035 | Jun 2035 |
| US 10,335,391 | In force Jun 2035 | Jun 2035 |
| US 10,751,325 | In force Jun 2035 | Jun 2035 |
| US 11,517,560 | In force Jun 2035 | Jun 2035 |
| US 12,350,255 | In force Jun 2035 | Jun 2035 |
| Application 19/210,851 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 2, 2015 Reel 35973, frame 574 | Sarpotdar, Pramod; Warner, Kevin; Zhang, Steven; Ahluwalia, Gurpreet; Kuang, Amy | Allergan, Inc. | Assignment of Assignor's Interest |
| Dec 5, 2018 Reel 47681, frame 466 | Allergan, Inc. | Aclaris Therapeutics, Inc. | Assignment of Assignor's Interest |
| Nov 1, 2019 Reel 50905, frame 290 | Aclaris Therapeutics, Inc. | Epi Health, LLC | Assignment of Assignor's Interest |
| Mar 14, 2022 Reel 59364, frame 509 | Epi Health, LLC | Evening Post Group, LLC | Security Interest |
| Jan 11, 2023 Reel 62347, frame 129 | Evening Post Group, LLC | Epi Health, LLC | Release of Security Interest |
| Dec 11, 2024 Reel 69557, frame 245 | Sarpotdar, Pramod; Warner, Kevin; Ahluwalia, Gurpreet; Kuang, Amy; Zhang, Steven | Allergan, Inc. | Assignment of Assignor's Interest |
| Dec 11, 2024 Reel 69557, frame 318 | Allergan, Inc. | Aclaris Therapeutics, Inc. | Assignment of Assignor's Interest |
| Dec 11, 2024 Reel 69599, frame 614 | Aclaris Therapeutics, Inc. | Epi Health, LLC | Assignment of Assignor's Interest |
| Dec 11, 2024 Reel 69557, frame 372 | Epi Health, LLC | Mayne Pharma LLC | Assignment of Assignor's Interest |
| Oct 26, 2026 Reel 76754, frame 805 | Epi Health, LLC | Mayne Pharma LLC | Corrective Assignment to Correct the Properties Section by Including Application Numbers That Were Omitted from the Previously Recorded Assignment as Well as Include Pages Missing from Assignment Previously Recorded on Reel 69557 Frame 372. Assignor(S) Hereby Confirms the Assignment of Assignor's Interest. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jun 2035
Term ends Jun 11, 2035. Maintenance fees still fall due before then
Citations
12
later US patents cite this one
That is above the median of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.